Correspondence 0001193125-23-267339 from CONTRAFECT Corp (CFRXQ) (CIK 0001478069)
CONTRAFECT Corp (CFRXQ) (CIK 0001478069)
Date: Oct. 31, 2023 · CIK: 0001478069 · Accession: 0001193125-23-267339
AI Filing Summary & Sentiment
File numbers found in text: 333-275148
Show Raw Text
CORRESP 1 filename1.htm CORRESP CONTRAFECT CORPORATION 28 Wells Avenue, Third Floor Yonkers, New York 10701 October 31, 2023 VIA EDGAR TRANSMISSION Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Joshua Gorsky Re: CONTRAFECT CORPORATION Registration Statement on Form S-1 (Registration No. 333-275148) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (Registration No. 333- 275148) (as amended, the “Registration Statement”) of ContraFect Corporation (the “Company”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on November 2, 2023, or at such later time as the Company or its counsel may orally request via telephone call to the staff. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Peter Handrinos at (617) 948-6060 or Wesley Holmes at (617) 948-6027. If you have any questions regarding the foregoing, please do not hesitate to contact Peter Handrinos at (617) 948-6060 or Wesley Holmes at (617) 948-6027, of Latham & Watkins LLP. Thank you in advance for your consideration. Very truly yours, CONTRAFECT CORPORATION. By: /s/ Michael Messinger Name: Michael Messinger Title: Chief Financial Officer cc: Peter N. Handrinos, Latham & Watkins LLP Wesley C. Holmes, Latham & Watkins LLP